Congress ticker disclosure profile

As of July 3 at 11:44 PM EDT

Public STOCK Act rows mentioning

NAIT

A factual page for public Congressional disclosures that reference NAIT. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.

90d rows

0

Feed lifetime

16

Member filers

2

Disclosed ranges

Amount not disclosed

Latest source-stamped receipts

Latest trade Dec 20, 2024

DateMemberActionAmountFiledReceipt
Dec 20, 2024Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Feb 23, 2024Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Aug 1, 2023Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Apr 1, 2022Ro KhannaSellAmount not disclosedDate not disclosedOpen card
Jun 3, 2019Ro KhannaBuyAmount not disclosedDate not disclosedOpen card
Mar 5, 2018Ro KhannaBuyAmount not disclosedDate not disclosedOpen card
Aug 18, 2017Ro KhannaSellAmount not disclosedDate not disclosedOpen card
Jul 28, 2017Michael T. McCaulSellAmount not disclosedDate not disclosedOpen card
Jul 17, 2017Ro KhannaBuyAmount not disclosedDate not disclosedOpen card
Jul 1, 2016Michael T. McCaulSellAmount not disclosedDate not disclosedOpen card
May 4, 2015Michael T. McCaulSellAmount not disclosedDate not disclosedOpen card
Dec 17, 2014Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Mar 27, 2014Michael T. McCaulSellAmount not disclosedDate not disclosedOpen card
Mar 5, 2014Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Feb 4, 2014Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Dec 16, 2013Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card

Source creed

This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 0 of 16 filed rows include disclosed amount ranges (0.0%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.

Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.